CD8A and neoplasm: Conducted in ovarian cancer, TNBC, mesothelioma, and CRC, these studies identified tumor–immune–gut axes linking specific microbial signatures with CD8+ T-cell infiltration, tumor mutational burden, and ICI responsiveness.